NO20000822L - Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander - Google Patents
Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorliganderInfo
- Publication number
- NO20000822L NO20000822L NO20000822A NO20000822A NO20000822L NO 20000822 L NO20000822 L NO 20000822L NO 20000822 A NO20000822 A NO 20000822A NO 20000822 A NO20000822 A NO 20000822A NO 20000822 L NO20000822 L NO 20000822L
- Authority
- NO
- Norway
- Prior art keywords
- substituted
- agonists
- carboxamides
- oxo
- receptor ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91818097A | 1997-08-25 | 1997-08-25 | |
PCT/US1998/017513 WO1999010347A1 (en) | 1997-08-25 | 1998-08-24 | Substituted 4-oxo-napthyridine-3-carboxamides as gaba brain receptor ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20000822D0 NO20000822D0 (no) | 2000-02-18 |
NO20000822L true NO20000822L (no) | 2000-04-13 |
Family
ID=25439933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20000822A NO20000822L (no) | 1997-08-25 | 2000-02-18 | Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1007526A1 (zh) |
JP (1) | JP2001514181A (zh) |
KR (1) | KR20010023313A (zh) |
CN (1) | CN1268136A (zh) |
AP (1) | AP2000001742A0 (zh) |
AU (1) | AU753800B2 (zh) |
BG (1) | BG104192A (zh) |
BR (1) | BR9811362A (zh) |
CA (1) | CA2301599C (zh) |
EG (1) | EG21717A (zh) |
HU (1) | HUP0003258A3 (zh) |
IL (1) | IL134291A0 (zh) |
IS (1) | IS5382A (zh) |
LV (1) | LV12539B (zh) |
NO (1) | NO20000822L (zh) |
NZ (1) | NZ502548A (zh) |
OA (1) | OA11293A (zh) |
PE (1) | PE130999A1 (zh) |
PL (1) | PL338783A1 (zh) |
SI (1) | SI20270A (zh) |
SK (1) | SK2162000A3 (zh) |
TW (1) | TW574221B (zh) |
WO (1) | WO1999010347A1 (zh) |
YU (1) | YU10500A (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4818000A (en) * | 1999-05-06 | 2000-11-21 | Neurogen Corporation | Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands |
WO2000071528A1 (en) * | 1999-05-25 | 2000-11-30 | Neurogen Corporation | 4h-1,4-benzothiazine-2-carboxamides and their use as gaba brain receptor ligands |
US6730682B2 (en) | 2000-07-12 | 2004-05-04 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
US6559145B2 (en) | 2000-07-12 | 2003-05-06 | Pharmacia & Upjohn Company | Heterocycle carboxamides as antiviral agents |
US6562822B2 (en) | 2000-07-12 | 2003-05-13 | Pharmacia & Upjohn Company | Heterocyle carboxamides as antiviral agents |
ES2287170T3 (es) | 2000-10-12 | 2007-12-16 | MERCK & CO., INC. | Aza- y poliaza-naftalenil-carboxamidas utilies como inhibidores de la vih integrasa. |
CA2425625A1 (en) | 2000-10-12 | 2002-07-18 | Merck & Co., Inc. | Aza-and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
WO2002030930A2 (en) | 2000-10-12 | 2002-04-18 | Merck & Co., Inc. | Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
US20020151591A1 (en) * | 2000-10-17 | 2002-10-17 | Anabella Villalobos | Combination use of acetylcholinesterase inhibitors and GABAa inverse agonists for the treatment of cognitive disorders |
SK10752003A3 (sk) * | 2001-03-01 | 2004-08-03 | Pfizer Products Inc. | Použitie inverzných agonistov GABAA v kombinácii s parciálnymi agonistami receptora nikotínu, estrogénom, selektívnymi modulátormi estrogénu alebo vitamínom E pri liečení kognitívnych porúch |
AR036256A1 (es) | 2001-08-17 | 2004-08-25 | Merck & Co Inc | Sal sodica de un inhibidor de integrasa del vih, procesos para su preparacion, composiciones farmaceuticas que lo contienen y su uso para la manufactura de un medicamento |
ATE370948T1 (de) | 2002-01-17 | 2007-09-15 | Merck & Co Inc | Hydroxynaphthyridinoncarbonsäureamide, die sich als inhibitoren der hiv-integrase eignen |
WO2003077850A2 (en) | 2002-03-15 | 2003-09-25 | Merck & Co., Inc. | N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7- carboxamides useful as hiv integrase inhibitors |
WO2004106336A1 (en) * | 2003-05-27 | 2004-12-09 | Pfizer Products Inc. | Process for the preparation and purification of 1,5-naphthyridine-3-carboxyamides |
WO2004106334A2 (en) * | 2003-05-28 | 2004-12-09 | Pfizer Products Inc. | Process for the preparation of 1,5-naphthyridine-3-carboxy amides by direct ester amidation |
PL2074123T3 (pl) * | 2006-10-16 | 2013-04-30 | Bionomics Ltd | Nowe związki o działaniu przeciwlękowym |
ES2610508T3 (es) * | 2006-11-22 | 2017-04-27 | Clinical Research Associates, Llc | Métodos para tratar el síndrome de Down, el síndrome del cromosoma X frágil y el autismo |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR204813A1 (es) * | 1972-05-08 | 1976-03-05 | Yamanouchi Pharma Co Ltd | Proceso para la preparacion de derivados de ampilicina |
GB1433774A (en) * | 1973-02-26 | 1976-04-28 | Allen & Hanburys Ltd | Heterocyclic compounds apparatus for conveying articles |
US4374138A (en) * | 1981-11-13 | 1983-02-15 | Warner-Lambert Company | Antibacterial amide compounds, compositions, and methods of use |
DD295360A5 (de) * | 1987-07-03 | 1991-10-31 | Akad Wissenschaften | Verfahren zur Herstellung von aktivierten Carbonsäureestern |
DD279887A1 (de) * | 1987-07-03 | 1990-06-20 | Inst Pharmakologische Forschun | Verfahren zur herstellung von d-alpha-(4(1h)-1,5-naphthyridon-3-carboxamido)-benzylpenicillin und anderen beta-lactamantibiotika |
DD279875A1 (de) * | 1987-07-03 | 1990-06-20 | Inst Pharmakologische Forschun | Verfahren zur herstellung von aktivierten carbonsaeureestern |
JPS6461461A (en) * | 1987-09-01 | 1989-03-08 | Otsuka Pharma Co Ltd | Benzohetero ring derivative |
-
1998
- 1998-08-24 WO PCT/US1998/017513 patent/WO1999010347A1/en not_active Application Discontinuation
- 1998-08-24 SI SI9820055A patent/SI20270A/sl unknown
- 1998-08-24 CA CA002301599A patent/CA2301599C/en not_active Expired - Fee Related
- 1998-08-24 HU HU0003258A patent/HUP0003258A3/hu unknown
- 1998-08-24 EP EP98943352A patent/EP1007526A1/en not_active Withdrawn
- 1998-08-24 PL PL98338783A patent/PL338783A1/xx unknown
- 1998-08-24 YU YU10500A patent/YU10500A/sh unknown
- 1998-08-24 CN CN98808578A patent/CN1268136A/zh active Pending
- 1998-08-24 AU AU91173/98A patent/AU753800B2/en not_active Ceased
- 1998-08-24 KR KR1020007001948A patent/KR20010023313A/ko not_active Application Discontinuation
- 1998-08-24 SK SK216-2000A patent/SK2162000A3/sk unknown
- 1998-08-24 BR BR9811362-3A patent/BR9811362A/pt not_active Application Discontinuation
- 1998-08-24 JP JP2000507675A patent/JP2001514181A/ja active Pending
- 1998-08-24 IL IL13429198A patent/IL134291A0/xx unknown
- 1998-08-24 NZ NZ502548A patent/NZ502548A/en unknown
- 1998-09-29 EG EG118098A patent/EG21717A/xx active
- 1998-10-23 TW TW87117597A patent/TW574221B/zh active
- 1998-11-13 PE PE1998001100A patent/PE130999A1/es not_active Application Discontinuation
-
2000
- 2000-02-01 AP APAP/P/2000/001742A patent/AP2000001742A0/en unknown
- 2000-02-18 OA OA1200000044A patent/OA11293A/en unknown
- 2000-02-18 NO NO20000822A patent/NO20000822L/no not_active Application Discontinuation
- 2000-02-22 IS IS5382A patent/IS5382A/is unknown
- 2000-02-25 BG BG104192A patent/BG104192A/xx unknown
- 2000-03-16 LV LVP-00-29A patent/LV12539B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU753800B2 (en) | 2002-10-31 |
BG104192A (en) | 2001-05-31 |
TW574221B (en) | 2004-02-01 |
SI20270A (sl) | 2000-12-31 |
PL338783A1 (en) | 2000-11-20 |
LV12539B (en) | 2001-01-20 |
CA2301599C (en) | 2003-03-25 |
CA2301599A1 (en) | 1999-03-04 |
JP2001514181A (ja) | 2001-09-11 |
PE130999A1 (es) | 1999-12-16 |
BR9811362A (pt) | 2000-08-22 |
NZ502548A (en) | 2002-06-28 |
LV12539A (en) | 2000-10-20 |
NO20000822D0 (no) | 2000-02-18 |
IS5382A (is) | 2000-02-22 |
OA11293A (en) | 2002-11-19 |
HUP0003258A2 (en) | 2001-03-28 |
YU10500A (sh) | 2002-10-18 |
AP2000001742A0 (en) | 2000-02-24 |
SK2162000A3 (en) | 2001-03-12 |
IL134291A0 (en) | 2001-04-30 |
WO1999010347A1 (en) | 1999-03-04 |
KR20010023313A (ko) | 2001-03-26 |
EP1007526A1 (en) | 2000-06-14 |
EG21717A (en) | 2002-02-27 |
HUP0003258A3 (en) | 2001-05-28 |
AU9117398A (en) | 1999-03-16 |
CN1268136A (zh) | 2000-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20000822L (no) | Substituerte 4-okso-3-karboksamider som GABA- hjernereseptorligander | |
CA2175204A1 (en) | Certain Fused Pyrrolecarboxanilides; a New Class of GABA Brain Receptor Ligands | |
HUP0000079A2 (hu) | Indán- és dihidroindolszármazékok | |
DK0555391T3 (da) | Visse imidazoquinoxaliner; en ny klasse GABA-receptorligander i hjernen | |
MX9805701A (es) | Nuevas pirrolcarboxamidas fusionadas; una nueva clase de ligandos del receptor cerebral gaba. | |
DE69636670D1 (de) | Benzimidazolverbindungen und ihre verwendung als gaba a receptor komplex modulatoren | |
US20030171395A1 (en) | Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands | |
WO1999043660A1 (en) | Substituted 1,4-dihydro-4-oxonicotinic carboxamides: gaba brain receptor ligands | |
DE69925462D1 (de) | Substituierte cycloalkyl-4-oxonicotinische karboxamide; gaba gehirn-rezeptorligande | |
HUP0303630A2 (hu) | Imidazo-pirimidin-származékok, mint GABA receptorok ligandumai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
DE69609413D1 (de) | BENZIMIDAZOLVERBINDUNGEN UND IHRE VERWENDUNG ALS MODULATOREN DES GABAa-REZEPTORKOMPLEXES | |
WO2002000623A3 (en) | Aryl fused substituted 4-oxy-pyridines | |
AU2321597A (en) | Novel imidazo{1,5-c}quinazolines; a new class of gaba brain receptor ligands | |
EP4025211A1 (en) | Methods of treating epilepsy using the same | |
PE20000325A1 (es) | Derivados de 2-ariletil-(piperidin-4-ilmetil)amina | |
BR0009539A (pt) | composto, composição farmacêutica, método para tratamento ou prevenção de uma doença ou distúrbio associado com agonismo patogênico, agonismo inverso ou antagonismo do receptor gaba a, uso de um composto, método para localizar receptores gaba a em uma amostra de tecido, método para alterar a atividade transdutora de sinal de receptores gaba a, método para o tratamento ou prevenção de distúrbios psicológicos associados com modulação do complexo receptor gaba a, e, processo para a preparação de um composto | |
ATE482931T1 (de) | Somatostatinrezeptor-1- und/oder -4-selektive agonisten und antagonisten | |
DE69926378D1 (de) | Oxo-pyridoimidazol-carboxamide: gaba-rezeptor-liganden im gehirn | |
TH42836A (th) | ซับสทิทิวเทด 4-ออกโซ-แนฟธิริดีน-3-คาร์บอกแซมีด; gaba เบรน รีเซปเตอร์ ลิแกนด์ | |
CA2249562A1 (en) | Certain fused pyrrolecarboxamides as gaba brain receptor ligands | |
BR112019028078A2 (pt) | derivados de 2-oxo-1,3-oxazolidinil imidazotiadiazol | |
AR007742A1 (es) | Pirrolcarboxanilidas fusionadas; una nueva clase de ligandos receptores gaba del cerebro. | |
TH35993A (th) | ฟิวส์ พิร์โรลคาร์บอกแซนิไลด์ | |
BR9807840A (pt) | Derivados de 4-aminoalcóxi-1,3-dihidrobenzoimidazol-2-tionas, sua preparação e seu uso como agonistas de auto-receptor de dopamina (d2) | |
MXPA01006351A (en) | Diphenylurea compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |